Literature DB >> 17882907

Paradoxical nasal obstruction: analysis of characteristics using acoustic rhinometry.

Hyo Yeol Kim1, Hun-Jong Dhong, Sang Duk Hong, Hyun Jong Lee, Hyun Jin Cho, Seung Kyu Chung.   

Abstract

BACKGROUND: The aim of this study was to determine the characteristics of acoustic rhinometric parameters in patients with paradoxical nasal obstruction.
METHODS: The medical records of 1844 patients who had nasal septal deviation between 1998 and 2004 at our institute were assessed retrospectively. The authors selected 31 subjects for the experimental group and 256 subjects for the control group. Minimal cross-sectional area (MCA), volume, and degree of mucosal change at baseline and decongested phase were analyzed.
RESULTS: MCA of the convex side in the baseline state for the experimental (paradoxical) group is wider than that for the control group (p = 0.005). Degree of mucosal change of the experimental group is smaller than that of the control group in the convex side (p = 0.001). Other parameters are similar for the two groups.
CONCLUSION: Patients with paradoxical nasal obstruction might be explained by less degree of mucosal change in the concave side of the nasal cavity during nasal cycle than the control group.

Entities:  

Mesh:

Year:  2007        PMID: 17882907     DOI: 10.2500/ajr.2007.21.3049

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  2 in total

1.  The intranasal Schirmer test: a preliminary study to quantify nasal secretion.

Authors:  Joerg Lindemann; Evangelia Tsakiropoulou; Gerhard Rettinger; Caroline Gutter; Marc Oliver Scheithauer; Valerie Picavet; Fabian Sommer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-17       Impact factor: 2.503

2.  Upper Airway Variation and Frequent Alcohol Consumption Can Affect Compliance With Continuous Positive Airway Pressure.

Authors:  Jong In Jeong; Hyo Yeol Kim; Sang Duk Hong; Gwanghui Ryu; Su Jin Kim; Kyung Eun Lee; Hun-Jong Dhong; Seung-Kyu Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-18       Impact factor: 3.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.